Browsing Over 32 Presentations
Sort By
How to deal with the different challenges in your professional career
YO Session
How to deal with social media - Self-representation and networking (ID 29)
Lecture Time
17:50 - 18:00
Speakers
- D. S. Dizon (Providence, United States of America, RI)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
How to deal with the different challenges in your professional career
YO Session
How to start an international collaboration - Developing and integrating research in clinical practice (ID 30)
Lecture Time
18:00 - 18:10
Speakers
- M. Mirza (Copenhagen, Denmark)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Authors
- M. Mirza (Copenhagen, Denmark)
How to deal with the different challenges in your professional career
YO Session
How to seize opportunities and progress your career in the gynae-oncology field (ID 31)
Lecture Time
18:10 - 18:20
Speakers
- C. Sessa (Bellinzona, Switzerland)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Authors
- C. Sessa (Bellinzona, Switzerland)
How to deal with the different challenges in your professional career
YO Session
Live Q&A and discussion (ID 32)
Lecture Time
18:20 - 19:05
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Best of abstracts session
Abstract session
Long term safety and secondary efficacy end points in the ENGOT-OV16/NOVA phase 3 trial on Niraparib in recurrent ovarian cancer (ID 24)
Lecture Time
12:55 - 13:05
Speakers
- M. Mirza (Copenhagen, Denmark)
Session Name
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session
Abstract session
Live Q&A and discussion (ID 25)
Lecture Time
13:15 - 13:30
Session Name
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session
Abstract session
Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: Efficacy and safety from ARIEL4, a randomized phase 3 study (ID 26)
Lecture Time
13:30 - 13:40
Speakers
- R. Kristeleit (London, United Kingdom)
Session Name
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session
Abstract session
Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC) (ID 27)
Lecture Time
13:40 - 13:50
Speakers
- K. N. Moore (Oklahoma City, United States of America, Oklahoma)
Session Name
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session
Abstract session
Discussion (ID 33)
Lecture Time
13:50 - 14:00
Speakers
- S. Banerjee (London, United Kingdom)
Session Name
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session
Abstract session
Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation (ID 12)
Lecture Time
12:45 - 12:55
Speakers
- A. Poveda Velasco (Valencia, Spain)
Session Name
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session
Abstract session
Live Q&A and discussion (ID 28)
Lecture Time
14:00 - 14:15
Session Name
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session
Abstract session
Discussion (ID 34)
Lecture Time
13:05 - 13:15
Speakers
- E. C. Kohn (Bethesda, United States of America)
Session Name
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15